Oxfendazole Development Group: Clinical Trials

3 trials sponsored by Oxfendazole Development Group, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 not yet recruiting. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Not yet recruiting 3
Phase 31Not yet recruiting 1

Follow Oxfendazole Development Group: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oxfendazole in Mild Parenchymal Brain Cysticercosis
Oxfendazole single dose, Oxfendazole three doses, albendazole plus praziquantel regime - Brain Cysticercosis
Phase 2 / Phase 3Not yet recruitingUniversidad Peruana Cayetano Heredia5442026-12-012026-05-01
One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis
Oxfendazole, Triclabendazole - Fascioliasis
Phase 2Not yet recruitingUniversidad Peruana Cayetano Heredia3362026-08-152026-06-03
Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults
Oxfendazole, Albendazole - Trichuris Infection
Phase 2Not yet recruitingOxfendazole Development Group2502024-07-012023-11-08

Conditions studied

Cysticercosis (1)  ·  Fascioliasis (1)  ·  Neurocysticercosis (1)  ·  Trichuriasis (1)

Interventions

oxfendazole (3)  ·  Albendazole (2)  ·  Triclabendazole (1)

Top investigators

Hector H Garcia, MD PhD (1)  ·  Hector H Garcia, MD, PhD (1)  ·  Lourdes Rodriguez, MD (1)  ·  Miguel M Cabada, MD MSc (1)

NIH funding

U01AI155323 (1)